tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Adial Pharmaceuticals Inc

ADIL
Add to Watchlist
3.360USD
+0.070+2.13%
Close 07-31 16:00（ET）Quotes delayed by 15 min
5.07MMarket Cap
LossP/E TTM

Adial Pharmaceuticals Inc

3.360
+0.070+2.13%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

ADIL Financials

See Adial Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Adial Pharmaceuticals Inc Earnings Date

Latest Release
May 8, 2026
EPS / Forecast
-1.48/-2.73
Revenue / Forecast
--/--
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-298.27
-338.58%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-333.11%-1.48
-465.27%-1.82
-438.49%-2.02
68.63%-0.18
84.46%-0.34
76.05%-0.32
68.04%-0.38
-161.13%-0.59
20.13%-2.19
51.59%-1.35
---1.18
--0.96
---2.75
---2.78
---9.94
----
----
----
----
----
Net Profit
9.26%-2.02M
3.60%-2.00M
18.17%-1.79M
20.33%-1.96M
65.59%-2.23M
-7.83%-2.07M
-58.26%-2.19M
-325.99%-2.46M
-122.88%-6.48M
33.01%-1.92M
55.46%-1.38M
128.27%1.09M
0.07%-2.91M
50.84%-2.87M
27.99%-3.11M
13.36%-3.85M
39.84%-2.91M
-68.07%-5.83M
-29.44%-4.32M
-145.21%-4.44M
Income Statement
Operating profit
11.72%-2.00M
2.85%-1.89M
20.23%-1.76M
17.69%-1.88M
-22.89%-2.27M
-8.80%-1.94M
-62.86%-2.21M
-54.82%-2.29M
18.68%-1.85M
31.32%-1.78M
46.84%-1.36M
54.45%-1.48M
25.83%-2.27M
41.40%-2.60M
37.13%-2.55M
26.34%-3.24M
36.80%-3.06M
-27.72%-4.43M
-21.72%-4.06M
-142.12%-4.40M
Net Profit
9.26%-2.02M
3.60%-2.00M
18.17%-1.79M
20.33%-1.96M
65.59%-2.23M
-7.83%-2.07M
-58.26%-2.19M
-325.99%-2.46M
-122.88%-6.48M
33.01%-1.92M
55.46%-1.38M
128.27%1.09M
0.07%-2.91M
50.84%-2.87M
27.99%-3.11M
13.36%-3.85M
39.84%-2.91M
-68.07%-5.83M
-29.44%-4.32M
-145.21%-4.44M
Balance Sheet
Current assets
82.68%4.80M
52.28%6.18M
-10.76%5.01M
58.98%6.08M
-50.73%2.63M
26.89%4.06M
394.82%5.62M
86.79%3.82M
80.00%5.34M
-33.08%3.20M
-83.24%1.14M
-79.41%2.05M
-77.13%2.96M
-26.03%4.78M
-15.18%6.77M
77.81%9.94M
110.05%12.96M
25.81%6.46M
-2.29%7.99M
-40.97%5.59M
Total current liabilities
14.01%1.51M
43.15%1.40M
39.29%1.15M
80.24%1.21M
135.36%1.32M
49.42%975.86K
56.96%829.05K
45.51%671.88K
-68.70%562.73K
-63.53%653.08K
-60.20%528.18K
-75.27%461.75K
-17.19%1.80M
-34.22%1.79M
-32.22%1.33M
-15.65%1.87M
6.31%2.17M
80.84%2.72M
79.13%1.96M
224.57%2.21M
Total assets
51.47%5.23M
32.30%6.67M
-15.68%5.66M
37.44%6.80M
-48.37%3.45M
6.49%5.04M
134.10%6.71M
30.95%4.95M
71.32%6.68M
-17.38%4.74M
-62.96%2.87M
-65.40%3.78M
-72.06%3.90M
-23.31%5.73M
-25.89%7.74M
35.48%10.92M
61.89%13.96M
36.12%7.47M
27.73%10.45M
-14.90%8.06M
Total liabilities
14.01%1.51M
43.15%1.40M
39.29%1.15M
80.24%1.21M
135.36%1.32M
49.42%975.86K
56.96%829.05K
45.51%671.88K
-77.14%562.73K
-73.41%653.08K
-77.36%528.18K
-84.41%461.75K
-24.40%2.46M
-38.08%2.46M
-28.14%2.33M
-8.41%2.96M
8.26%3.26M
163.53%3.97M
196.99%3.25M
374.25%3.23M
Total equity
74.79%3.72M
29.70%5.28M
-23.43%4.51M
30.72%5.59M
-65.26%2.13M
-0.38%4.07M
151.52%5.88M
28.93%4.28M
325.16%6.12M
24.63%4.08M
-56.75%2.34M
-58.33%3.32M
-86.55%1.44M
-6.59%3.28M
-24.88%5.41M
64.87%7.96M
90.60%10.71M
-12.00%3.51M
1.62%7.20M
-45.08%4.83M
Cash Flow Statement
Net operating income
-1.70%-1.61M
8.89%-1.32M
-8.22%-1.83M
18.57%-1.75M
2.51%-1.59M
-20.65%-1.45M
-21.79%-1.69M
-136.43%-2.15M
29.26%-1.63M
31.18%-1.20M
59.14%-1.39M
74.29%-908.59K
7.93%-2.30M
26.22%-1.75M
3.56%-3.40M
-10.33%-3.53M
12.19%-2.50M
9.22%-2.37M
-59.82%-3.53M
-225.15%-3.20M
Net investment
-100.00%0.00
--0.00
--0.00
--0.00
--150.00K
----
----
----
----
--350.00K
--350.00K
--800.00K
----
--0.00
--0.00
100.00%0.00
100.00%0.00
100.00%0.00
--0.00
---33.73K
Net financing
522.50%315.28K
--2.60M
-85.47%524.68K
1188.88%5.30M
-98.68%50.65K
-100.00%0.00
2503.61%3.61M
708677.59%411.09K
527.33%3.82M
--3.38M
--138.67K
-96.89%58.00
-93.32%609.61K
-100.00%0.00
-100.00%0.00
-99.93%1.86K
123.59%9.12M
--1.25M
478.94%5.50M
-39.68%2.81M

FAQs

What are the current assets of Adial Pharmaceuticals Inc?

According to Adial Pharmaceuticals Inc's FY2025 earnings report, its current assets were 6.18M, with a year-on-year change of 52.28.

What are the total assets of Adial Pharmaceuticals Inc?

According to Adial Pharmaceuticals Inc's FY2025 earnings report, its total assets of Adial Pharmaceuticals Inc were 6.67M, with a year-on-year change of 32.30.

What are the total liabilities of Adial Pharmaceuticals Inc?

According to Adial Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Adial Pharmaceuticals Inc were 1.40M, with a year-on-year change of 43.15.

What is the total equity of Adial Pharmaceuticals Inc?

According to Adial Pharmaceuticals Inc's FY2025 earnings report, its total equity of Adial Pharmaceuticals Inc was 5.28M, with a year-on-year change of 29.70.

What is the net operating income of Adial Pharmaceuticals Inc?

According to Adial Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Adial Pharmaceuticals Inc was -7.80M, with a year-on-year change of 5.85.

What is the net financing of Adial Pharmaceuticals Inc?

According to Adial Pharmaceuticals Inc's FY2025 earnings report, its net financing of Adial Pharmaceuticals Inc was 8.47M, with a year-on-year change of 8.00.

What is the Earnings Per Share (EPS) of Adial Pharmaceuticals Inc?

According to Adial Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -298.27, with a year-on-year change of -338.58.

What is the net income of Adial Pharmaceuticals Inc?

According to Adial Pharmaceuticals Inc's FY2025 earnings report, its net income was -7.98M, with a year-on-year change of 39.56.

What is the Return on Equity (ROE) of Adial Pharmaceuticals Inc?

According to Adial Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -170.73, with a year-on-year change of 47.27.

What is the Return on Assets (ROA) of Adial Pharmaceuticals Inc?

According to Adial Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -136.16, with a year-on-year change of 49.55.

What is the operating profit of Adial Pharmaceuticals Inc?

According to Adial Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -7.80M, with a year-on-year change of 5.85.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy